Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Ordinary Shares and Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated  Other Comprehensive Loss, Net of Tax	Non- controlling Interests
Beginning Balance (in shares) at Dec. 31, 2020		225.5
Beginning Balance at Dec. 31, 2020	$ 3,583	$ 6,314	$ 1,042	$ (3,861)	$ 88
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	933		913		20
Shares issued - employee stock compensation plans (in shares)		0.9
Shares issued - employee stock compensation plans	(87)	$ (87)
Shares repurchased (in shares)		(0.2)
Shares repurchased	(50)		(50)
Share-based compensation expense	131	$ 131
Dividends to shareholders	(104)		(104)
Net change in fair value of financial instruments	11			11
Net foreign currency translation adjustments	(70)			(70)
Net postretirement benefit obligation	29			29
Purchases of subsidiary shares from noncontrolling interests	(14)	$ (8)			(6)
Dividends paid to noncontrolling interests on subsidiary common stock	(1)				(1)
Ending Balance (in shares) at Mar. 31, 2021		226.2
Ending Balance at Mar. 31, 2021	4,361	$ 6,350	1,801	(3,891)	101
Beginning Balance (in shares) at Dec. 31, 2020		225.5
Beginning Balance at Dec. 31, 2020	3,583	$ 6,314	1,042	(3,861)	88
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	435
Net change in fair value of financial instruments	5
Net foreign currency translation adjustments	(108)
Net postretirement benefit obligation	87
Ending Balance (in shares) at Sep. 30, 2021		221.4
Ending Balance at Sep. 30, 2021	2,299	$ 6,531	(445)	(3,877)	90
Beginning Balance (in shares) at Mar. 31, 2021		226.2
Beginning Balance at Mar. 31, 2021	4,361	$ 6,350	1,801	(3,891)	101
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	393		379		14
Shares issued - employee stock compensation plans (in shares)		0.5
Shares issued - employee stock compensation plans	(52)	$ (52)
Shares repurchased (in shares)		(1.1)
Shares repurchased	(242)		(242)
Share-based compensation expense	85	$ 85
Dividends to shareholders	(115)		(115)
Net change in fair value of financial instruments	(1)			(1)
Net foreign currency translation adjustments	115			115
Net postretirement benefit obligation	33			33
Dividends paid to noncontrolling interests on subsidiary common stock	(10)				(10)
Ending Balance (in shares) at Jun. 30, 2021		225.6
Ending Balance at Jun. 30, 2021	4,567	$ 6,383	1,823	(3,744)	105
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(891)		(900)		9
Shares issued - employee stock compensation plans (in shares)		0.2
Shares issued - employee stock compensation plans	17	$ 18	(1)
Shares repurchased (in shares)		(4.4)
Shares repurchased	(1,251)		(1,251)
Share-based compensation expense	130	$ 130
Dividends to shareholders	(116)		(116)
Net change in fair value of financial instruments	(5)			(5)
Net foreign currency translation adjustments	(153)			(153)
Net postretirement benefit obligation	25			25
Dividends paid to noncontrolling interests on subsidiary common stock	(24)				(24)
Ending Balance (in shares) at Sep. 30, 2021		221.4
Ending Balance at Sep. 30, 2021	$ 2,299	$ 6,531	(445)	(3,877)	90
Beginning Balance (in shares) at Dec. 31, 2021	214.8	214.8
Beginning Balance at Dec. 31, 2021	$ 1,158	$ 6,626	(1,694)	(3,871)	97
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,048		1,023		25
Shares issued - employee stock compensation plans (in shares)		0.9
Shares issued - employee stock compensation plans	(116)	$ (116)
Shares repurchased (in shares)		(2.8)
Shares repurchased	(828)		(828)
Share-based compensation expense	119	$ 119
Dividends to shareholders	(110)		(110)
Net change in fair value of financial instruments	1			1
Net foreign currency translation adjustments	(7)			(6)	(1)
Net postretirement benefit obligation	33			33
Dividends paid to noncontrolling interests on subsidiary common stock	(7)				(7)
Ending Balance (in shares) at Mar. 31, 2022		212.9
Ending Balance at Mar. 31, 2022	$ 1,291	$ 6,629	(1,609)	(3,843)	114
Beginning Balance (in shares) at Dec. 31, 2021	214.8	214.8
Beginning Balance at Dec. 31, 2021	$ 1,158	$ 6,626	(1,694)	(3,871)	97
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,980
Net change in fair value of financial instruments	(16)
Net foreign currency translation adjustments	(1,119)
Net postretirement benefit obligation	$ 87
Ending Balance (in shares) at Sep. 30, 2022	207.6	207.6
Ending Balance at Sep. 30, 2022	$ (670)	$ 6,774	(2,638)	(4,919)	113
Beginning Balance (in shares) at Mar. 31, 2022		212.9
Beginning Balance at Mar. 31, 2022	1,291	$ 6,629	(1,609)	(3,843)	114
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	514		501		13
Shares issued - employee stock compensation plans (in shares)		0.4
Shares issued - employee stock compensation plans	(50)	$ (50)
Shares repurchased (in shares)		(1.7)
Shares repurchased	(500)		(500)
Share-based compensation expense	92	$ 92
Dividends to shareholders	(119)		(119)
Net change in fair value of financial instruments	(9)			(9)
Net foreign currency translation adjustments	(436)			(436)
Net postretirement benefit obligation	28			28
Dividends paid to noncontrolling interests on subsidiary common stock	(23)				(23)
Ending Balance (in shares) at Jun. 30, 2022		211.6
Ending Balance at Jun. 30, 2022	788	$ 6,671	(1,727)	(4,260)	104
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	418		408		10
Shares issued - employee stock compensation plans (in shares)		0.2
Shares issued - employee stock compensation plans	10	$ 11	(1)
Shares repurchased (in shares)		(4.2)
Shares repurchased	(1,200)		(1,200)
Share-based compensation expense	93	$ 93
Dividends to shareholders	(118)		(118)
Net change in fair value of financial instruments	(8)			(8)
Net foreign currency translation adjustments	(676)			(677)	1
Net postretirement benefit obligation	26			26
Purchases of subsidiary shares from noncontrolling interests	(2)	$ (1)			(1)
Dividends paid to noncontrolling interests on subsidiary common stock	$ (1)				(1)
Ending Balance (in shares) at Sep. 30, 2022	207.6	207.6
Ending Balance at Sep. 30, 2022	$ (670)	$ 6,774	$ (2,638)	$ (4,919)	$ 113